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Background and purpose — Late prosthetic joint infections 
(PJIs) are a growing medical challenge as more and more joint 
replacements are being performed and the expected lifespan of 
patients is increasing. We analyzed the incidence rate of late PJI 
and its temporal trends in a nationwide population.
Patients and methods — 112,708 primary hip and knee replace-
ments performed due to primary osteoarthritis (OA) between 
1998 and 2009 were followed for a median time of 5 (1–13) years, 
using data from nationwide Finnish health registries. Late PJI 
was detected > 2 years postoperatively, and very late PJI was 
detected > 5 years postoperatively.
Results — During the follow-up, involving 619,299 prosthesis-
years, 1,345 PJIs were registered: cumulative incidence 1.20% 
(95% CI: 1.13–1.26) (for knees, 1.41%; for hips, 0.92%). The inci-
dence rate of late PJI was 0.069% per prosthesis-year (CI: 0.061–
0.078), and it was greater after knee replacement than after hip 
replacement (0.080% vs. 0.057%, p = 0.006). The incidence rate 
of very late PJI was 0.051% per prosthesis-year (CI: 0.042–0.063), 
0.058% for knees and 0.044% for hips (p = 0.2). The incidence 
rate of late PJI varied between 0.041% and 0.107% during the 
years of observation without any temporal trend (incidence rate 
ratio (IRR) = 0.98, 95% CI: 0.93–1.03). Very late PJI increased 
from 0.026% in 2004 to 0.056% in 2010 (IRR = 1.11, 95% CI: 
1.02–1.20). 
Interpretation — In our nationwide study, the incidence rate of 
late PJI after hip or knee arthroplasty was approximately 0.07% 
per prosthesis-year. The incidence of very late PJI appeared to 
increase.

The incidence, temporal trends, and risk factors for postop-
erative prosthetic joint infections (PJIs) after hip and knee 
replacements have been widely studied in various settings and 
with various study designs (Phillips et al. 2006, Pulido et al. 
2008, Jämsen et al. 2009a, Dale et al. 2012). In most studies, 
the follow-up time is 1–5 years. 
Late PJIs (PJIs occurring more than 2 years after arthro-
plasty) are more rare than early and delayed postoperative 
PJIs, and they may occur many years after the joint replace-
ment (Zimmerli et al. 2004, Sendi et al. 2011), making their 
epidemiology challenging to analyze. In some earlier single-
center and multicenter studies as well as in studies based on 
Medicare data, the cumulative incidence of late PJI has been 
between 0.3% and 0.9% (Ainscow and Denham 1984, Made-
razo et al. 1988, Kaandorp et al. 1997, Cook et al. 2007, Ong 
et al. 2009, Kurtz et al. 2010, Tsaras et al. 2012). The sizes 
of study population, methods for identification of PJI, and 
follow-up times have varied. 
As more and more joint replacements are performed annu-
ally (Nemes et al. 2014) and the expected lifespan of patients 
with joint replacements is increasing, the number of patients 
who are at risk of late PJI is growing. Also, the threshold 
for operating vulnerable patients with chronic diseases has 
become lower (Singh and Lewallen 2014). 
Because information on the incidence of late PJI is scarce, 
we analyzed the incidence of late PJI and its temporal trends 
in a nationwide primary hip and knee replacement population 
(due to primary osteoarthritis), with a cumulative follow-up 
time of 619,299 prosthesis-years. Patients of all age groups 
were included.
Material and methods
We selected primary hip and knee replacements performed 
due to primary osteoarthritis in Finland between January 1, 
1998 and December 31, 2009. The operations were identified 
from the PERFECT database (http://www.thl.fi/en_US/web/
en/project?id=21963) of the Finnish National Institute for 
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Health and Welfare. The underlying methodology has been 
described elsewhere (Peltola et al. 2011, Jämsen et al. 2013). 
The purpose of the database, created by combining records 
from several Finnish health registries, is to provide nationwide 
data about the outcomes of hip and knee replacements in Finn-
ish citizens. It is known that the Finnish Arthroplasty Register 
alone does not detect all cases of PJI (Jämsen et al. 2009a, 
Huotari et al. 2010). 
In this study, we used records derived from the Finnish 
Arthroplasty Register and the Hospital Discharge Register. 
The Finnish Arthroplasty Register (FAR) has been collect-
ing data on joint replacements since 1980, and since 1997 
reporting to the register has been mandatory (Puolakka et al. 
2001). The Hospital Discharge Register (HDR) is based on 
mandatory discharge reports, and it covers all inpatient care 
(i.e. in both private and public hospitals). Since 1997, the 
International Classification of Diseases, Tenth Revision (ICD-
10), has been used for registering diagnoses and the Nordic 
Medico-Statistical Committee classification (NOMESCO) 
has been used for registering surgical procedures. In general, 
HDR is considered to be a reliable source of data (Sund 2012), 
the accuracy of orthopedic diagnoses being about 90% or 
higher (Sund et al. 2007, Mattila et al. 2008). Both registries 
include data on deaths, derived from Statistics Finland (offi-
cial statistics of Finland).
119,584 operations were identified in the FAR and the HDR. 
In order to obtain detailed operative data, we excluded 4,203 
operations registered in the HDR but lacking corresponding 
records in the FAR, and 2,673 operations in which data on 
prosthesis type and fixation were lacking in the FAR. Hence, 
112,708 operations were included in the analyses, representing 
94% of the primary hip and knee replacements for osteoarthri-
tis performed in Finland during the study period (Figure 1).
Outcomes
In the FAR, revision joint replacements and resection arthro-
plasties (removal of a prosthesis) performed due to infection 
(according to the operating surgeon’s report) were considered 
to be PJIs. In the HDR, PJIs were identified by (1) a diagnosis 
code indicating PJI (T84.5), or (2) a diagnosis code indicat-
ing PJI (T84.5) or wound infection (T81.4), accompanied by 
a surgical procedure code indicating resection arthroplasty 
(NFU00, NGU00), revision joint replacement (NFC*, NGC*), 
arthrodesis (NGG30, NGG34), debridement (NFA*, NFF20, 
NFF25, NGA20, NGA30, NGF*), operation for infection 
(NFS*, NFW*, NGS*, NGW*), or amputation (NFQ20). The 
diagnosis code T81.4 combined with the selected operation 
codes was included because of the possibility of miscoding 
between T84.5 and T81.4. Two years after the primary opera-
tion, there are no superficial wound infections; when analyz-
ing the late and very late PJIs, this should not cause any mis-
classification.
The PJIs identified were linked to the corresponding pri-
mary operations (based on Finnish citizens’ unique personal 
identification numbers) and operated joint (hip or knee, and 
laterality). As the operated side is routinely recorded in the 
FAR, PJIs identified from that registry (as well as correspond-
ing records in the HDR) could be reliably linked. In the HDR, 
data concerning the affected side were missing for most PJIs. 
To link these events to primary operations, we used data con-
cerning the patients’ other joint replacements (as registered in 
the FAR, from 1980 to 2010). Of the 1,699 PJIs identified in 
total, 354 (including 157 surgical procedures for the treatment 
of PJI and 197 hospitalizations with the diagnosis code T84.5) 
could not be reliably linked to the primary procedure and were 
excluded from the main analysis.
Prosthetic joints that were not infected were excluded from 
further follow-up (censored) according to the time of aseptic 
revision, the date of the patient’s death, or on December 31, 
2010. All patients were followed up for at least 1 year unless 
death or revision occurred before that. The maximum follow-
up time was 13 years.
PJIs were classified according to the time of presentation, as 
early (< 3 months after surgery), delayed (3–24 months after 
surgery), or late (> 24 months after surgery) (Zimmerli et al. 
2004). Because postoperative PJIs caused by low-virulence 
bacteria, e.g. coagulase-negative staphylococci or Propioni-
bacterium acnes, can sometimes be even more delayed than 2 
years (Portillo et al. 2013), we also analyzed very late PJIs (> 
5 years after primary surgery) separately. 
Figure 1. The study population. a Included in the sensitivity analyses.a Included in the sensitivity analyses       
Primary hip and knee arthroplasties performed
due to primary osteoarthritis in Finland between
1998 and 2009 as reported in Hospital Discharge
Register (HDR) or Finnish Arthroplasty Register
(FAR)
(n = 119,584)
Operations with no record in FAR
excluded (n = 4,203)
Number of operations available for identification
of PJI (n = 112,078)
Number of PJIs identified (n = 1,699)
Operations with missing data on
prosthesis type or fixation excluded
(n = 2,673)
Number of PJIs available for analysis (n = 1,345)
564 (42%) detected first in FAR
782 (58%) detected first in HDR
PJIs excluded due to unreliable
linkage (n = 354) a
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Statistics
The incidence of PJI was computed in 2 ways: (1) as the cumu-
lative incidence of PJI throughout the follow-up time, and (2) 
as the incidence rate of PJIs per prosthesis-year. The incidence 
rates were calculated separately for each postoperative follow-
up year. To account for deaths during each observation year 
and the effect of increasing annual operation numbers, we used 
the mid-year number of prostheses as the denominator when 
calculating the incidence rates. 95% confidence intervals (CIs) 
were calculated by Wilson’s method (Altman et al. 2000). Uni-
variate analyses for categorical variables were calculated with 
the chi-squared test. Time trends in PJI incidence were tested 
with Poisson regression. The statistical significance of the tem-
poral changes in treatment practices for late and very late PJIs 
(i.e. in the proportions of PJIs treated with or without removal 
or exchange of the prosthesis) were tested with ordinary least-
squares regression. The data were analyzed with SPSS version 
19.0 for Windows and Stata version 12.0.
Sensitivity analyses of cumulative incidences, incidence 
rates, and their time trends were performed to test how (1) 
exclusion of all simultaneous bilateral operations and (2) 
inclusion of the 354 PJIs whose linkage to joint replacement 
data was uncertain, would affect the results of the original 
analyses. To eliminate the possible influence of linkage prob-
lems, we also separately analyzed the 51,751 patients who had 
had only one joint operated between 1980 and 2011. 
Ethics
The institutional review board of the National Institute for 
Health and Welfare gave permission for this study. The PER-
FECT project had previously been approved by the ethics 
committee of the same institution (THL 1406/6.02.00/2009).
results
112,708 primary hip replacements (45%) and knee replace-
ments (55%) due to primary osteoarthritis that were performed 
in Finland between 1998 and 2009 were included (92,626 
patients). 4,731 operations (4.2%) were bilateral. The annual 
numbers of joint replacements increased (Figure 2).
The mean age of the patients at the time of the primary 
operation was 69 (21–102) years. 29% of the patients were 
under 65 years of age. 64% of the joint replacements were 
performed in females.
The median follow-up time was 5.0 (1–13) years. The total 
cumulative follow-up time was 619,299 prosthesis-years. Sur-
veillance of the joint replacement ended because of patient 
death in 14,123 cases (13%) and because of aseptic revision in 
3,023 cases (2.7%).
1,345 PJIs occurred (cumulative incidence = 1.20%, CI: 
1.13–1.26). 630 (47%) of the PJIs were early (< 3 months 
after surgery), 435 (32%) were delayed (3–24 months after 
surgery), and 280 (21%) were late (> 2 years after surgery).
The late PJI incidence rate was 0.069% per prosthesis-
year (280 of 405,653, CI: 0.061–0.078% per prosthesis-year) 
(Table 1, see Supplementary data). The incidence rate of very 
late PJIs (detected > 5 years postoperatively) was 0.051% per 
prosthesis-year (91 of 177,624, CI: 0.042–0.063% per pros-
thesis-year). 
The cumulative incidence of PJI was greater after knee 
replacement (1.41%) than after hip replacement (0.92%), 
especially during the first 2 postoperative years (Table 2, 
see Supplementary data). Also, late PJIs occurred more fre-
quently after knee replacement than after hip replacemen 
(Figure 3), the incidence rates of late PJI being 0.080% (CI: 
0.69–0.93) and 0.057% (CI: 0.45–0.69) per prosthesis-year 
(p = 0.006).
The incidence rate of late PJI varied between 0.041% and 
0.11% per prosthesis-year over the years of observation (inci-
dence rate ratio (IRR) = 0.98, CI: 0.93–1.03). Very late PJI 
increased from 0.026% per prosthesis-year in 2004 to 0.056% 
per prosthesis-year in 2010 (IRR = 1.11, CI: 1.02–1.20). The 
proportion of late PJIs treated with prosthesis removal or 
exchange declined from 5 out of 7 in 2000 to 21 out of 54 in 
Figure 2. Numbers of primary hip and knee replacements due to pri-
mary osteoarthritis in Finland by year of operation.
Figure 3. The incidence of PJI following hip and knee replacement per 
surveillance year. The error bars indicate 95% confidence intervals.
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2010 (p = 0.003), and the proportion of very late PJIs declined 
from 2 out of 2 to 5 out of 26 (p < 0.001). 
When the PJIs with uncertain linkage were also taken into 
account, the incidence of late and very late PJI increased to 
approximately 0.1% per prosthesis-year. The increase in the 
incidence of very late PJI remained statistically significant if 
simultaneous bilateral operations were excluded, but not if 
PJIs with uncertain linkage were included or if only 1 joint 
was operated (Table 3, see Supplementary data).
Discussion
In this nationwide analysis with more than 600,000 prosthe-
sis-years surveyed, the incidence rate of late PJI in hip and 
knee prostheses was about 0.07% per prosthesis-year, and 
higher after knee replacements than after hip replacements. 
The annual risk of PJI stabilized after 3–5 years postopera-
tively to about 0.05% per year. During the study period, the 
incidence of very late PJI increased. 
The strengths of this study were the large sample size and 
the truly nationwide study population with no exclusions by, 
for example, age or socioeconomic status. With comprehen-
sive health register data, the follow-up was complete. Every 
prosthesis could be uniquely followed. The prosthesis was 
censored if revised for aseptic reasons, so postoperative PJIs 
from revision operations were not misclassified as late PJIs. 
In addition, with the exception of possible miscoding, most 
PJIs were probably registered—because PJIs are normally 
diagnosed and treated in hospital. With the use of HDR data, 
we could also identify PJIs treated without removal or pros-
thesis exchange, or even conservatively. This is important, as 
reoperations other than revision joint replacements are poorly 
captured by arthroplasty registers (Jämsen et al. 2009b, Huo-
tari et al. 2010).
A major limitation in our study was the restricted data 
content of the registry-based dataset. Information on micro-
biological findings, possible remote infections, or the sources 
of the bacteria were not available. Secondly, some PJIs may 
have been missed. This applies particularly to nonoperatively 
treated infections where the diagnosis code did not indicate the 
prosthesis joint involvement (e.g. in the setting of septicemia). 
Because of the increasing use of debridement and change of 
mobile parts with implant retention, the proportion of non-
operatively treated PJIs may have decreased during the study 
period, affecting the time trends in PJI. Even so, we believe 
that the cases coded as PJIs probably represented true case—
and it is more likely that we missed some PJIs than that we had 
false-positive PJI cases. Thirdly, the linkage of the HDR data 
to joint replacement data led to certain problems in patients 
with several prosthetic joints. As we excluded these PJIs with 
linkage problems from the major analyses, the true incidence 
rates may actually have been higher than we have reported. 
However, despite the challenges with registry data, national 
registry-based studies like ours or international multicenter 
studies are needed to achieve sufficiently large study popula-
tions to examine time trends in the rare late and very late PJIs.
The overall cumulative PJI incidence of 1.2% (with a higher 
rate in knees than in hips) is in line with the results of other 
studies (Zimmerli et al. 2004, Pulido et al. 2008). When our 
incidences by each postoperative surveillance year (Table 2, 
see Supplementary data) are compared to US Medicare data 
(Ong et al. 2009, Kurtz et al. 2010) and Nordic arthroplasty 
registers (Dale et al. 2012), the time trend in the annual inci-
dence of PJI was quite similar: the incidence is the highest 
during the first 2 postoperative years and then the annual risk 
of PJI stabilizes to a lower level.
The cumulative incidence of PJI detected later than 2 years 
from the operation in the Medicare data was 0.59% for hips 
(Ong et al. 2009) and 0.46% for knees (Kurtz et al. 2010). 
In another population-based study from Minnesota, USA, the 
figure was 0.7%, and—similar to our results—the incidence 
was higher for knees than for hips (Tsaras et al. 2012). In 
the 1980s, Maderazo et al. (1988) estimated the cumulative 
incidence of late PJIs to be 0.6%. The cumulative incidences 
of PJI after 2 years in our study were slightly lower (0.22% 
for hips and 0.27% for knees) than results reported by Ains-
cow and Denham (1984) (0.27%). The cumulative incidences 
depend strongly on the length of the follow-up time and on 
case detection and definition (e.g. whether possible aseptic 
revisions and their infection complications are excluded).
The incidence rates of late or hematogenous PJI per prosthe-
sis-year at risk was studied by Ainscow and Denham (1984) in 
a population of 1,112 total joint replacements with a mean fol-
low-up time of 6 years. These authors reported an incidence of 
0.04% per prosthesis-year. More recently, Cook et al. (2007) 
found an incidence of late PJI of 0.05% per prosthesis-year 
with an average follow-up time of 10 years in 3,013 total knee 
replacements similar to ours.
An increase in cumulative PJI incidences, including both 
postoperative and late PJIs, has been reported from the USA 
and the Nordic countries (Dale et al. 2012, Kurtz et al. 2012). 
In our study also, the incidence of very late PJI increased (but 
not statistically significantly) from 0.026% per prosthesis-year 
in 2004 to 0.056% per prosthesis-year in 2010. The reasons 
could not be analyzed in our study, and we cannot exclude the 
possibility that changes in the treatment protocols–namely the 
more active use of debridement and change of mobile parts 
with implant retention—have affected the possibility of PJIs 
being registered. Possible additional explanations include 
growing numbers of patients with predisposing comorbidi-
ties (Singh and Lewallen 2014) and an increasing incidence of 
bacteremia (de Kraker et al. 2013).
In summary, according to our large nationwide study the 
risk of late PJI was approximately 0.07% per prosthesis-year, 
and it was higher for knees than for hips. During the study 
period, the incidence of PJIs that were registered very late (> 
5 years after surgery) appeared to increase, which justifies 
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future monitoring of the incidence of late PJI and study of the 
reasons for the increase. 
Supplementary data
Tables 1–3 are available at Acta’s website (www.actaorthop.
org), identification number 8258.
Design of the study: KH and EJ. Data analysis and writing of the manuscript: 
KH, MP, and EJ.
The abstract was published at the thirty-third annual meeting of the European 
Bone and Joint Infection Society, Utrecht, the Netherlands (11–13 September 
2014). Abstract book F120, pages 110-111.
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